Ellen Gendler
Dermatology · New York, NYNPI 1891997409
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 92.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $21,989 and has fallen 97.0% since, to $654 in 2025.
Across 170 payments — averaging $206.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$32K
- Merz North America, Inc.$1K
- Revance Therapeutics, Inc.$404
- Novartis$160
- Johnson & Johnson$133
- Almirall LLC$102
- plus $652 from 12 others
What the payments were for
- Consulting fees$18,61553%
- Speaking & faculty fees$9,60527%
- Travel & lodging$2,1436%
- Food & beverage$4,67913%
- Education$1330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 100 | $32,467 |
| Merz North America, Inc. | 12 | $1,257 |
| Revance Therapeutics, Inc. | 13 | $404 |
| Novartis | 6 | $160 |
| Johnson & Johnson | 5 | $133 |
| Almirall LLC | 5 | $102 |
| Lilly USA, LLC | 4 | $94 |
| Incyte Corporation | 4 | $87 |
| Galderma Laboratories, L.p. | 4 | $80 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $71 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Sun Pharmaceutical Industries Inc. | 3 | $60 |
| VYNE Pharmaceuticals Inc. | 3 | $53 |
| UCB, Inc. | 2 | $48 |
| Organon | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Aclaris Therapeutics, Inc. | 1 | $22 |
| LEO Pharma Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$21,604
- XEOMIN$699
- ASCLERA$299
- BOTOX$150
- DAXXIFY$125
How this compares
$35,175 in reported general payments places this provider in the 85th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 24 | $940 |
| ValacyclovirValacyclovir Hcl | 54 | $762 |
| Tretinoin | 11 | $737 |
| Estradiol | 12 | $635 |
| Spironolactone | 26 | $302 |
| Mupirocin | 15 | $143 |
| Minoxidil | 13 | $65 |
| Triamcinolone Acetonide | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.